No Data
No Data
Generation Bio(GBIO.US) Officer Sells US$18,410.06 in Common Stock
$Generation Bio(GBIO.US)$ Officer Paone Antoinette sold 6,719 shares of common stock on Jul 1, 2024 at an average price of $2.74 for a total value of $18,410.06.Source: Announcement What is statement
Insiders At Generation Bio See Good Returns After Buying Stock Worth US$778.9k
Insiders who bought Generation Bio Co. (NASDAQ:GBIO) stock lover the last 12 months are probably not as affected by last week's 23% loss. After taking the recent loss into consideration, the US$778.9
Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit
CAMBRIDGE, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (NASDAQ:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff
JMP Securities Maintains Generation Bio(GBIO.US) With Hold Rating
JMP Securities analyst Silvan Tuerkcan maintains $Generation Bio(GBIO.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 36.4% and a total average return of 4.1% ove
Analysts' Opinions Are Mixed on These Healthcare Stocks: Generation Bio (GBIO), LAVA Therapeutics (LVTX) and Aura Biosciences Inc (AURA)
Generation Bio Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Sales Results.
Generation Bio Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Sales Results.